Considering also the older age of the MSH2/MSH6 mutation carriers diagnosed with EC, age-selective screening is not necessary or feasible in the case of MMR deficiency due to other than MLH1 protein loss [3]. Here, MLH1 is linked to mismatch repair cancer syndrome 1.